Avista Healthcare Partners announced it has signed a definitive agreement to acquire sanotact Group GmbH, a Germany-based vitamins, minerals, and supplements platform, alongside strategic co-investor Damier Group. Existing investor FLOTTE Beteiligungen GmbH will reinvest in the company as part of the transaction.
Headquartered in Münster, Germany, sanotact develops, manufactures, and commercializes vitamins, minerals, and supplements products through a diversified model that combines a scaled CDMO platform with a portfolio of branded offerings, including the sanotact® brand. The company supports leading drugstore and distribution customers across 80 international markets and offers capabilities across major VMS dosage forms.
Avista said the acquisition aligns with its focus on consumer healthcare and preventative health trends, marking its ninth platform investment in the sector. The firm noted that sanotact’s innovation capabilities, manufacturing quality, and established market position provide a strong foundation for continued international expansion and growth.
Damier Group said the investment reflects its strategy of backing companies positioned to benefit from long-term consumer health and self-care trends across Europe.
The transaction also extends Avista’s ongoing partnership with Damier founder Yvan Vindevogel and his family office. Existing shareholder FLOTTE will continue supporting the business through a significant reinvestment.
The transaction remains subject to regulatory approvals.
KEY QUOTES:
“sanotact represents a compelling opportunity to invest in a premier independent VMS platform in Europe. The Company is well-positioned to benefit from strong secular tailwinds, including rising consumer focus on preventative health. sanotact’s differentiated capabilities, strong innovation engine, and established market position provide a solid foundation to drive robust growth. We look forward to partnering with management to support sanotact’s next phase of development.”
Thompson Dean, Chairman, Avista Healthcare Partners
“sanotact fits squarely within Damier’s investment philosophy of backing platforms that anticipate long-term consumer health trends. The shift toward self-care continues to accelerate across Europe, and sanotact’s understanding of customer needs positions the company well to capture this growth. Under Martin Spengler’s leadership, the team has consistently translated the company’s vision into strong financial results, a testament to sanotact’s strategy and execution. We are proud to support the company alongside Avista and FLOTTE in this next chapter.”
Yvan Vindevogel, Founder, Damier Group
“We are excited to partner with Avista, Damier and FLOTTE as we continue to build on sanotact’s strong momentum. Both Avista and Damier bring deep healthcare expertise, network and a proven track record of supporting growth and strategic expansion, which will enable us to further enhance our innovation capabilities, expand our international footprint, and continue delivering high-quality products to our customers.”
Martin Spengler, Chief Executive Officer, sanotact
“It was extremely important for us to find new partners who shared our long-term vision, as well as our commitment to quality and strong customer relationships that have defined sanotact over the years. We are delighted to partner with Avista and Damier, and believe their experience and strategic perspective make them ideal partners to support the Company’s future development.”
Haymo Modelhart, Chairman, FLOTTE Beteiligungen GmbH
